Good Clinical Practices in Pharmaceuticals (eBook, PDF)
Redaktion: Bunn, Graham P.
52,95 €
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
52,95 €
Als Download kaufen
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
26 °P sammeln
Good Clinical Practices in Pharmaceuticals (eBook, PDF)
Redaktion: Bunn, Graham P.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book provides a thorough reference on Good Clinical Practice (GCP) which is the international ethical, scientific and practical standard to which all clinical research is conducted.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
Andere Kunden interessierten sich auch für
- Good Manufacturing Practices for Pharmaceuticals, Seventh Edition (eBook, PDF)48,95 €
- Good Design Practices for GMP Pharmaceutical Facilities (eBook, PDF)48,95 €
- Susanne ProkschaPractical Guide to Clinical Data Management (eBook, PDF)188,95 €
- John SharpGood Pharmaceutical Manufacturing Practice (eBook, PDF)65,95 €
- Good Laboratory Practice Regulations (eBook, PDF)183,95 €
- Good Clinical Practices in Pharmaceuticals (eBook, ePUB)52,95 €
- Good Pharmaceutical Freeze-Drying Practice (eBook, PDF)52,95 €
-
-
-
This book provides a thorough reference on Good Clinical Practice (GCP) which is the international ethical, scientific and practical standard to which all clinical research is conducted.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 206
- Erscheinungstermin: 26. November 2024
- Englisch
- ISBN-13: 9781040166260
- Artikelnr.: 72284251
- Verlag: Taylor & Francis
- Seitenzahl: 206
- Erscheinungstermin: 26. November 2024
- Englisch
- ISBN-13: 9781040166260
- Artikelnr.: 72284251
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Graham P. Bunn has been the president of GB Consulting LLC, in Pennsylvania, since 2000 and provides regulatory compliance guidance and technical consulting services for pharmaceutical, biotechnology, and other FDA¿related industries. His experience includes supporting and leading teams for quality systems assessments, regulatory action responses and remediations (FDA483, Warning Letter, Consent Decree), and preparing sites to host regulatory inspections. He has developed and facilitated numerous highly interactive learning workshops worldwide, including Aseptic Training Programs, Batch Record Reviews, QA on the Floor, and aseptic training support for Compounding Centers. Before founding GB Consulting LLC, Graham gained extensive experience through various management positions in the pharmaceutical industry with SmithKline Beecham PLC (GlaxoSmithKline PLC), Wyeth Pharmaceuticals (Pfizer), and Astra Merck Inc. (AstraZeneca PLC). His career includes management responsibilities as a corporate compliance auditor, quality assurance, validation, and clinical trials manufacturing and packaging. Graham is the editor of Good Manufacturing Practices for Pharmaceuticals and Good Laboratory Practices for Non¿Clinical Studies and the author of several book chapters/journal articles. Graham received a BSc in pharmacy from Brighton University, England, and an MSc in Quality Assurance and Regulatory Affairs from Temple University, Philadelphia, and is a member of the Regulatory Affairs Professional Society (RAPS).
Preface
About the Editor
List of Contributors
Introduction
1 Regulatory Application Requirements
Shanthi Ganeshan and Connie Freund
2
John Klein and Sonya Edgerton
3
Sam Sather and Jennifer Lawyer
4 and Sonya Edgerton
5
Karen Truhe
6 21 CFR 50 - Informed Consent
Joe Near
7
Glenda Guest
8
Aurea Flores
9 Protected Health Information and Privacy in Clinical Trials (HIPAA)
Sam Sather
10 Good Pharmacovigilance Practices (GVP)
Jessica Chu
11 Data Integrity and 21CFR11 for GCPs
Randall Basinger
12 Preparing for FDA inspections at sponsor/investigator sites
Tommy Lee and Sam Sather
13 Regulations relating to the Placebo response in Clinical research
Graham Bunn and Arthur Ooghe
About the Editor
List of Contributors
Introduction
1 Regulatory Application Requirements
Shanthi Ganeshan and Connie Freund
2
John Klein and Sonya Edgerton
3
Sam Sather and Jennifer Lawyer
4 and Sonya Edgerton
5
Karen Truhe
6 21 CFR 50 - Informed Consent
Joe Near
7
Glenda Guest
8
Aurea Flores
9 Protected Health Information and Privacy in Clinical Trials (HIPAA)
Sam Sather
10 Good Pharmacovigilance Practices (GVP)
Jessica Chu
11 Data Integrity and 21CFR11 for GCPs
Randall Basinger
12 Preparing for FDA inspections at sponsor/investigator sites
Tommy Lee and Sam Sather
13 Regulations relating to the Placebo response in Clinical research
Graham Bunn and Arthur Ooghe
Preface
About the Editor
List of Contributors
Introduction
1 Regulatory Application Requirements
Shanthi Ganeshan and Connie Freund
2
John Klein and Sonya Edgerton
3
Sam Sather and Jennifer Lawyer
4 and Sonya Edgerton
5
Karen Truhe
6 21 CFR 50 - Informed Consent
Joe Near
7
Glenda Guest
8
Aurea Flores
9 Protected Health Information and Privacy in Clinical Trials (HIPAA)
Sam Sather
10 Good Pharmacovigilance Practices (GVP)
Jessica Chu
11 Data Integrity and 21CFR11 for GCPs
Randall Basinger
12 Preparing for FDA inspections at sponsor/investigator sites
Tommy Lee and Sam Sather
13 Regulations relating to the Placebo response in Clinical research
Graham Bunn and Arthur Ooghe
About the Editor
List of Contributors
Introduction
1 Regulatory Application Requirements
Shanthi Ganeshan and Connie Freund
2
John Klein and Sonya Edgerton
3
Sam Sather and Jennifer Lawyer
4 and Sonya Edgerton
5
Karen Truhe
6 21 CFR 50 - Informed Consent
Joe Near
7
Glenda Guest
8
Aurea Flores
9 Protected Health Information and Privacy in Clinical Trials (HIPAA)
Sam Sather
10 Good Pharmacovigilance Practices (GVP)
Jessica Chu
11 Data Integrity and 21CFR11 for GCPs
Randall Basinger
12 Preparing for FDA inspections at sponsor/investigator sites
Tommy Lee and Sam Sather
13 Regulations relating to the Placebo response in Clinical research
Graham Bunn and Arthur Ooghe